Sorrento Therapeutics Inc (SRNE) stock is lower by -78.02% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 30 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 8. SRNE's rank also includes a long-term technical score of 10.
SRNE has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on SRNE!
Sorrento Therapeutics Inc (SRNE) stock has gained 4.4% while the S&P 500 is up 2.64% as of 3:39 PM on Wednesday, Nov 30. SRNE is up $0.05 from the previous closing price of $1.25 on volume of 6,334,349 shares. Over the past year the S&P 500 has fallen -11.05% while SRNE is lower by -78.02%. SRNE lost -$1.33 per share in the over the last 12 months.
Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
